These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26780402)

  • 21. Metabolic Aspects of Anthracycline Cardiotoxicity.
    Russo M; Della Sala A; Tocchetti CG; Porporato PE; Ghigo A
    Curr Treat Options Oncol; 2021 Feb; 22(2):18. PubMed ID: 33547494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Cardenolide Glycoside Acovenoside A Affords Protective Activity in Doxorubicin-Induced Cardiotoxicity in Mice.
    Ezzat SM; El Gaafary M; El Sayed AM; Sabry OM; Ali ZY; Hafner S; Schmiech M; Jin L; Syrovets T; Simmet T
    J Pharmacol Exp Ther; 2016 Aug; 358(2):262-70. PubMed ID: 27247000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model.
    Freiwan M; Kovács MG; Kovács ZZA; Szűcs G; Dinh H; Losonczi R; Siska A; Kriston A; Kovács F; Horváth P; Földesi I; Cserni G; Dux L; Csont T; Sárközy M
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 6-maleimidocaproyl hydrazone derivative of doxorubicin (DOXO-EMCH) is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage.
    Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Kratz F; Walker UA
    Int J Cancer; 2007 Feb; 120(4):927-34. PubMed ID: 17131338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
    Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
    Mohamed HE; Asker ME; Ali SI; el-Fattah TM
    J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Doxorubicin Myocardial Injury: Inflammatory, Oxidative Stress, and Apoptotic Role of Galectin-3.
    Al-Salam S; Kandhan K; Sudhadevi M; Yasin J; Tariq S
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity.
    Wang F; Iskra B; Kleinerman E; Alvarez-Florez C; Andrews T; Shaw A; Chandra J; Schadler K; Aune GJ
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):208-215. PubMed ID: 29557918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart rate dynamics in doxorubicin-induced cardiomyopathy.
    Lončar-Turukalo T; Vasić M; Tasić T; Mijatović G; Glumac S; Bajić D; Japunžić-Žigon N
    Physiol Meas; 2015 Apr; 36(4):727-39. PubMed ID: 25798626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings.
    Barış VÖ; Gedikli E; Yersal N; Müftüoğlu S; Erdem A
    Amino Acids; 2019 Nov; 51(10-12):1649-1655. PubMed ID: 31673792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin induces senescence and impairs function of human cardiac progenitor cells.
    Piegari E; De Angelis A; Cappetta D; Russo R; Esposito G; Costantino S; Graiani G; Frati C; Prezioso L; Berrino L; Urbanek K; Quaini F; Rossi F
    Basic Res Cardiol; 2013 Mar; 108(2):334. PubMed ID: 23411815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early myocardial changes induced by doxorubicin in the nonfailing dilated ventricle.
    Rodrigues PG; Miranda-Silva D; Costa SM; Barros C; Hamdani N; Moura C; Mendes MJ; Sousa-Mendes C; Trindade F; Fontoura D; Vitorino R; Linke WA; Leite-Moreira AF; Falcão-Pires I
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H459-H475. PubMed ID: 30525890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycine protects against doxorubicin-induced heart toxicity in mice.
    Shosha MI; El-Ablack FZ; Saad EA
    Amino Acids; 2023 May; 55(5):679-693. PubMed ID: 36967438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice.
    Weinstein DM; Mihm MJ; Bauer JA
    J Pharmacol Exp Ther; 2000 Jul; 294(1):396-401. PubMed ID: 10871338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy.
    Cappetta D; Esposito G; Piegari E; Russo R; Ciuffreda LP; Rivellino A; Berrino L; Rossi F; De Angelis A; Urbanek K
    Int J Cardiol; 2016 Feb; 205():99-110. PubMed ID: 26730840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling.
    Hsu WT; Huang CY; Yen CYT; Cheng AL; Hsieh PCH
    Theranostics; 2018; 8(12):3176-3188. PubMed ID: 29930721
    [No Abstract]   [Full Text] [Related]  

  • 37. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.
    Räsänen M; Degerman J; Nissinen TA; Miinalainen I; Kerkelä R; Siltanen A; Backman JT; Mervaala E; Hulmi JJ; Kivelä R; Alitalo K
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13144-13149. PubMed ID: 27799559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.
    Rea D; Coppola C; Barbieri A; Monti MG; Misso G; Palma G; Bimonte S; Zarone MR; Luciano A; Liccardo D; Maiolino P; Cittadini A; Ciliberto G; Arra C; Maurea N
    In Vivo; 2016; 30(3):279-90. PubMed ID: 27107087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-10 Levels are Associated with Doxorubicin-Related Cardiotoxicity in Breast Cancer Patients in a One-Year Follow-Up Study.
    Alves MT; Simões R; Pestana RMC; de Oliveira AN; Oliveira HHM; Soares CE; Sabino AP; Silva LM; Gomes KB
    Immunol Invest; 2022 May; 51(4):883-898. PubMed ID: 33557640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage.
    Zingarelli B; Hake PW; Yang Z; O'Connor M; Denenberg A; Wong HR
    FASEB J; 2002 Mar; 16(3):327-42. PubMed ID: 11874982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.